Eukaryotic RNA Polymerase II

RNA polymerase II (RNAP II) is a 550 kDa multiprotein complex composed of 12 subunits. Here is the latest research on RNAP II and its role it regulating transcription and transcription-coupled recombination repair.

January 13, 2021
Open Access

Protein over-expression in Escherichia coli triggers adaptation analogous to antimicrobial resistance

Microbial Cell Factories
Jack JamesDeclan A Doyle
December 24, 2020
Open Access

TBPL2/TFIIA complex establishes the maternal transcriptome through oocyte-specific promoter usage

Nature Communications
Changwei YuLászló Tora
January 16, 2021
Review
Open Access

Why is a paediatric respiratory specialist integral to the paediatric rheumatology clinic?

Breathe
Manisha RamphulJayesh Mahendra Bhatt
January 15, 2021
Open Access

Induction of spontaneous human neocentromere formation and long-term maturation

The Journal of Cell Biology
Marina Murillo-PinedaLars E T Jansen
January 12, 2021
Open Access

First Report of Leaf spot Caused by Xylaria arbuscula on Flue-cured Tobacco in China

Plant Disease
Hong-Lian XieCai-Hua Shi
January 13, 2021

Circular RNAs as Biomarkers and Therapeutic Targets in Cancer

Seminars in Cancer Biology
Aferin BeilerliAamir Ahmad
January 9, 2021
Preprint
Open Access

An "individualist" model of an active genome in a developing embryo

BioRxiv : the Preprint Server for Biology
S.-K. HuangChristine Rushlow
January 22, 2021

CKAP2L promotes non-small cell lung cancer progression through regulation of transcription elongation.

Cancer Research
Tiziana MonteverdeMichela Garofalo
January 15, 2021

Adaptive responses to mTOR gene targeting in hematopoietic stem cells reveal a proliferative mechanism evasive to mTOR inhibition

Proceedings of the National Academy of Sciences of the United States of America
Cuiqing FanYi Zheng
January 14, 2021

Co-transcriptional splicing regulates 3' end cleavage during mammalian erythropoiesis

Molecular Cell
Kirsten A ReimerKarla M Neugebauer
January 19, 2021
Open Access

Engineered miniature H1 promoters with dedicated RNA polymerase II or III activity.

The Journal of Biological Chemistry
Zongliang GaoBen Berkhout
January 21, 2021
Open Access

JAK3 Is Expressed in the Nucleus of Malignant T Cells in Cutaneous T Cell Lymphoma (CTCL).

Cancers
Chella Krishna VadivelAnders Woetmann
January 25, 2021
Preprint
Open Access

DamID transcriptional profiling identifies the Snail/Scratch transcription factor Kahuli as Alk target in the Drosophila visceral mesoderm.

BioRxiv : the Preprint Server for Biology
P. Mendoza-GarciaRuth H Palmer
January 21, 2021
Open Access

Acute stress drives global repression through two independent RNA polymerase II stalling events in Saccharomyces.

Cell Reports
Nitika BadjatiaB Franklin Pugh

Sign up to follow this feed and discover related papers.

Related Feeds

Alternative splicing

Alternative splicing a regulated gene expression process that allows a single genetic sequence to code for multiple proteins. Here is that latest research.

Archaeal RNA Polymerase

Archaeal RNA polymerases are most similar to eukaryotic RNA polymerase II but require the support of only two archaeal general transcription factors, TBP (TATA-box binding protein) and TFB (archaeal homologue of the eukaryotic general transcription factor TFIIB) to initiate basal transcription. Here is the latest research on archaeal RNA polymerases.

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

CRISPR & Single Cell Analyses

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on CRISPR-Cas applications relevant to single cell analyses. Here is the latest research.

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.

CRISPR (general)

Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). CRISPR-Cas system enables the editing of genes to create or correct mutations. Discover the latest research on CRISPR here.

CRISPR Genome Editing & Therapy

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of this system for gene editing and therapy in human diseases.

CRISPR Ribonucleases Deactivation

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on mechanisms that underlie deactivation of CRISPR ribonucleases. Here is the latest research.

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

CRISPR for Genome Editing

Genome editing technologies enable the editing of genes to create or correct mutations. Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). Here is the latest research on the use of CRISPR-Cas system in gene editing.

© 2021 Meta ULC. All rights reserved
/feed-previews/eukaryotic-rna-polymerase-ii/804a982b-d814-4455-9796-69988abf0667